PPT: Autoimmune Disease Diagnosis Market to Witness Huge Growth during 2021-2026

1
Global Autoimmune Disease Diagnosis Market
Research and Forecast Report 2021-2026




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Autoimmune Disease Diagnosis Market
Research Report According to the latest report
by IMARC Group, titled "Autoimmune Disease
Diagnosis Market Global Industry Trends, Share,
Size, Growth, Opportunity and Forecast
2021-2026," the global autoimmune disease
diagnosis market reached a strong growth in 2020.
An autoimmune disease refers to a medical
condition that results from an abnormal immune
response to a normally functioning body part. The
immune system is unable to distinguish between
healthy tissues and potentially harmful antigens
in this condition. As a result, it releases
proteins called autoantibodies to attack the
healthy cells that destroy the functioning cells,
tissues, and organs of the body. At present, more
than 80 types of autoimmune disorders have been
identified by scientists that include type I
diabetes, psoriasis, rheumatoid arthritis,
multiple sclerosis and inflammatory bowel
disease. The diagnosis of these diseases
requires a combination of physical examination,
antinuclear antibody test (ANA), C-reactive
protein (CRP), tissue biopsy and X-rays in order
to determine the nature and severity of the
condition. Request Free Sample Report
https//www.imarcgroup.com/autoimmune-disease-diag
nosis-market/requestsample
4
Report Description and Highlights
Report Description
Global Autoimmune Disease Diagnosis Market Trends
The global market is primarily driven by the
growing prevalence of numerous autoimmune
disorders, along with the increasing demand for
precise and efficient diagnostic solutions. This
has led to the adoption of advanced technologies
to conduct multiple tests simultaneously with
faster and accurate results. These technologies
are also focused on providing an improved
diagnosis with higher sensitivity, which is
providing an impetus to the market growth. In
addition to this, there has been a rising
preference for laboratory automation. This, along
with the increasing healthcare expenditure, is
acting as a major growth-inducing factor.
Moreover, numerous government and non-government
organizations (NGOs) are undertaking initiatives
to spread awareness regarding the diagnosis and
treatment of autoimmune disorders. Several
research and diagnostics institutes are also
investing in programs that aim to develop
improved diagnostic methods and novel therapeutic
solutions for these medical disorders, which, in
turn, is expected to create a positive outlook
for the market. Looking forward, the market
value is projected to reach a strong growth
during the forecast period (2021-2026).

5
Report Description and Highlights
Report Description

• Market Summary
• Breakup by Product Type
• Consumables and Assay Kits
• Instruments
•  
• Breakup by Disease Type
• Systemic Autoimmune Disease
• Rheumatoid Arthritis
• Psoriasis
• Systemic Lupus Erythematosus (SLE)
• Multiple Sclerosis
• Others
• Localized Autoimmune Disease
• Inflammatory Bowel Disease
• Type 1 Diabetes
• Thyroid
• Others

6
Report Description and Highlights
Report Description

• Breakup by Test Type
• Routine Laboratory Tests
• Inflammatory Markers
• Autoantibodies and Immunologic Tests
• Others
• Breakup by End-User
• Clinical Laboratories
• Hospitals
• Others
• Breakup by Region
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India

7
Report Description and Highlights
Report Description

• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Argentina
• Columbia
• Chile
• Peru
• Others

8
Report Description and Highlights
Report Description

• Middle East and Africa Turkey
• Saudi Arabia
• Iran
• United Arab Emirates
• Others
• Note We are updating our reports, If you want
  latest primary and secondary data (2021-2026)
  with Cost Module, Business Strategy, Distribution
  Channel, etc. Click request free sample report.
• Competitive Landscape with Key Players
• Abbott Laboratories
• Aesku.Diagnostics GmbH Co. KG
• Beckman Coulter Inc. (Danaher Corporation)
• bioMérieux SA (Institut Mérieux)
• Bio-Rad Laboratories Inc.
• Euroimmun AG (PerkinElmer Inc.)
• Hemagen Diagnostics Inc.
• Inova Diagnostics Inc. (Werfen Group S.A.)
• Myriad Genetics Inc.
• Quest Diagnostics Incorporated

9
Report Description and Highlights
Report Description

• Siemens Healthineers AG (Siemens AG)
• SQI Diagnostics
• Thermo Fisher Scientific Inc.
• Trinity Biotech
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/autoimmune-disease-diag
  nosis-market

10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
13

Contact Us